MedTrace Logo

Using a New Human Milk Fortifier to Optimize Feeding

NCT04283799 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2021-06-09

No results posted yet for this study

Summary

This study aims to compare the safety and efficacy of a new HMF and those of other HMF used before in very preterm infants.

Conditions

  • Preterm Infant
  • Growth

Interventions

DIETARY_SUPPLEMENT

A new human milk fortifier

Contents of protein, protein/energy ratio, moderate hydrolysis of whey protein, medium-chain fatty acid are increased in the new HMF

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Yun Cao, Ph.D., M.D. · Children's Hospital of Fudan University, Shanghai, China

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-16
Primary Completion
2021-04-23
Completion
2021-04-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04283799 on ClinicalTrials.gov